YA

Yash Arun Joshi

Active Director Director DIN 01424296
DIN 01424296 First appointment Jul 2005 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jul 2005
Shareholding value •••• Premium profile

About Yash Arun Joshi

Data last updated:

Yash Arun Joshi is a Director at Surya Life Sciences Limited (since 2005), Director at Surya Remedies Private Limited (since 2010) and Director at Solana Life Sciences Private Limited (since 2019), and holds 1 more current directorship. The companies operate in Chemicals and Materials and Pharma. The 4 current companies with reported revenue have a combined latest revenue of ₹168 Cr; the largest is Surya Life Sciences Limited at ₹119 Cr (FY 2025). Earlier, Yash Arun Joshi was a Director at Witting Biotech Private Limited (2019–2022).

DIN 01424296
Primary Designation Director
Industry Chemicals and Materials
First Appointment 04 Jul 2005
Oldest Company Age 33 yrs
Largest company Surya Life Sciences Limited · ₹119 Cr (FY 2025)
Combined revenue ₹168 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Surya Life Sciences Limited U24230MH2005PLC154467
Director04 Jul 20052005₹119 Cr (FY 2025)Active
Surya Remedies Private Limited U24110GJ1993PTC019642
Director21 Jul 20101993₹28.86 Cr (FY 2024)Active
Solana Life Sciences Private Limited U24231MP1999PTC013742
Director26 Jun 20191999₹16.49 Cr (FY 2024)Active
Griffith Overseas Private Limited U24290GJ2016PTC094790
Director20 Dec 20162016₹3.65 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Witting Biotech Private Limited U24239MP2019PTC048368
Director16 Apr 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Surya Remedies Private Limited
Surya Life Sciences Limited
Solana Life Sciences Private Limited
Griffith Overseas Private Limited
Premium access

Shareholding and investment profile for Yash Arun Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yash Arun Joshi

Yash Arun Joshi currently holds 4 directorships: Surya Life Sciences Limited (Director, since 04 Jul 2005, revenue ₹119 Cr (FY 2025)); Surya Remedies Private Limited (Director, since 21 Jul 2010, revenue ₹28.86 Cr (FY 2024)); Solana Life Sciences Private Limited (Director, since 26 Jun 2019, revenue ₹16.49 Cr (FY 2024)); Griffith Overseas Private Limited (Director, since 20 Dec 2016, revenue ₹3.65 Cr (FY 2024)).

Yash Arun Joshi was first appointed on 04 Jul 2005 as Director at Surya Life Sciences Limited. The most recent appointment on record is 26 Jun 2019 at Solana Life Sciences Private Limited.

The 4 current companies of Yash Arun Joshi that report revenue have a combined latest revenue of ₹168 Cr: Surya Life Sciences Limited ₹119 Cr (FY 2025); Surya Remedies Private Limited ₹28.86 Cr (FY 2024); Solana Life Sciences Private Limited ₹16.49 Cr (FY 2024); Griffith Overseas Private Limited ₹3.65 Cr (FY 2024).

Yash Arun Joshi held 1 earlier board appointment: Witting Biotech Private Limited (Director, 16 Apr 2019 to 20 Mar 2022).

The current boards of Yash Arun Joshi's companies include Arun Durgaprasad Joshi (Surya Life Sciences Limited), Neha Yash Joshi (Surya Life Sciences Limited), Sandhya Arunbhai Joshi (Surya Life Sciences Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available